Flecainide (a class 1c antiarrhythmic) produces a dose-dependent decrease in intracardiac conduction. Its well known common electrocardiographic effects are prolongation of PR and QT intervals and the QRS complex duration. We report a case of flecainide toxicity in an elderly female who presented with a type 1 Brugada pattern who essentially had a previously normal ECG pattern on therapeutic dose of flecainide therapy. The case describes a rare electrocardiographic abnormality induced by flecainide toxicity which otherwise could be easily misinterpreted as a ST-segment elevation myocardial infarction (STEMI) without lack of expertise and high clinical suspicion
Brugada syndrome was described in 1992 as a new clinical and electrocardiographic syndrome involving...
Brugada syndrome was described in 1992 as a new clinical and electrocardiographic syndrome involving...
Anti-arrhythmic drugs (AADs) uniquely affect the various electrolyte channels in the heart and can s...
AbstractFlecainide (a class 1c antiarrhythmic) produces a dose-dependent decrease in intracardiac co...
A 64-year-old female with paroxysmal atrial fibrillation presented to the emergency department with ...
Brugada pattern can be found on the electrocardiogram (ECG) of patients with altered mental status, ...
Summary BACKGROUND: Flecainide, a class IC antiarrhythmic drug, is used frequently in patients wi...
The patient is a 58-year-old white male cardiologist whofirst came to attention in 2004 at the age o...
AbstractA 45-year old man presents with stable monomorphic ventricular tachycardia. He had previousl...
A 45-year old man presents with stable monomorphic ventricular tachycardia. He had previously been d...
Aims The typical Brugada ECG pattern consists of a prominent J-wave associated with ST-segment eleva...
The Brugada electrocardiogram pattern is characterized by coved-type ST-elevation (>2 mm) in the rig...
Brugada syndrome (BS) is associated with sudden cardiac death in patients with a structurally normal...
The Brugada syndrome (BrS) is an electrical heart disease with complex inheritance (some cases with ...
Brugada syndrome (BrS) has been described as an arrhythmic disorder characterized by ST elevation wi...
Brugada syndrome was described in 1992 as a new clinical and electrocardiographic syndrome involving...
Brugada syndrome was described in 1992 as a new clinical and electrocardiographic syndrome involving...
Anti-arrhythmic drugs (AADs) uniquely affect the various electrolyte channels in the heart and can s...
AbstractFlecainide (a class 1c antiarrhythmic) produces a dose-dependent decrease in intracardiac co...
A 64-year-old female with paroxysmal atrial fibrillation presented to the emergency department with ...
Brugada pattern can be found on the electrocardiogram (ECG) of patients with altered mental status, ...
Summary BACKGROUND: Flecainide, a class IC antiarrhythmic drug, is used frequently in patients wi...
The patient is a 58-year-old white male cardiologist whofirst came to attention in 2004 at the age o...
AbstractA 45-year old man presents with stable monomorphic ventricular tachycardia. He had previousl...
A 45-year old man presents with stable monomorphic ventricular tachycardia. He had previously been d...
Aims The typical Brugada ECG pattern consists of a prominent J-wave associated with ST-segment eleva...
The Brugada electrocardiogram pattern is characterized by coved-type ST-elevation (>2 mm) in the rig...
Brugada syndrome (BS) is associated with sudden cardiac death in patients with a structurally normal...
The Brugada syndrome (BrS) is an electrical heart disease with complex inheritance (some cases with ...
Brugada syndrome (BrS) has been described as an arrhythmic disorder characterized by ST elevation wi...
Brugada syndrome was described in 1992 as a new clinical and electrocardiographic syndrome involving...
Brugada syndrome was described in 1992 as a new clinical and electrocardiographic syndrome involving...
Anti-arrhythmic drugs (AADs) uniquely affect the various electrolyte channels in the heart and can s...